I have come across certain companies which take money from big dermatology product selling brands to test their products. And they call it clinical testing on patients. And the way the methodology is just by after they give the product to the patient, that is to the subjects. And after two or three months, they give a questionnaire and the results are based on the questionnaire and some visual confirmation. And some studies may not even have a control or a placebo group. In order to test this, another independent party made a fake product claiming that it will smoothen out the skin, give glow, and reduce wrinkles. And then they approached the same company which conducts tests for major brands for skin care. And they accepted the product, conducted the test, and showed and the results showed significant improvement and it was published as such. So the study which you took to prove that ethylenescopic acid gets absorbed into the skin and causes benefits, that is the vitamin C benefits, is that study, such a study, what is the strength of evidence and the quality of those studies where topical vitamin C in the form of ethylenescopic acid has an effect on the skin when used.
Searching PubMed
ascorbic acid topical skin vitamin C clinical trials
Searching PubMed
ethyl ascorbic acid topical skin absorption efficacy
Searching the Web
cosmetic clinical study quality evidence topical vitamin C ascorbic acid skin efficacy RCT placebo controlled
Searching PubMed
cosmetic dermatology research quality bias industry funded
Reading Article
Searching the Web
cosmetic clinical testing fraud fake product questionnaire no control group dermatology research quality problem
Searching PubMed
topical vitamin C ascorbic acid randomized controlled trial skin aging collagen
Searching PubMed
cosmetic clinical trial methodology bias self reported outcomes industry sponsorship
Reading Article
Reading Article
Searching the Web
ethyl ascorbic acid 3-O-ethyl ascorbic acid skin penetration evidence clinical study quality
Now I have enough to give a thorough, honest answer. Let me synthesize everything.
Evidence Quality for Topical Vitamin C (Including Ethyl Ascorbic Acid / 3-O-Ethyl Ascorbic Acid)
Your concern is entirely legitimate and reflects a well-known structural problem in cosmetic research. Let me break this down carefully.
Part 1: The Problem You're Describing is Real and Documented
What you are describing - industry-funded "consumer perception" or "clinical efficacy" studies using self-reported questionnaires, no placebo/control group, and visual confirmation by a non-blinded assessor - is a recognized category of weak evidence in cosmetic dermatology. It sits at the very bottom of the evidence hierarchy:
| Level | Study Type |
|---|---|
| 1 | Systematic Reviews / Meta-analyses of RCTs |
| 2 | RCTs (randomized, controlled, blinded) |
| 3 | Non-randomized controlled trials |
| 4 | Cohort / case-control studies |
| 5 | Case series, expert opinion |
| Below 5 | Industry-funded, no-control, questionnaire-only "consumer perception" studies |
The fake-product experiment you are describing has actually been documented in the cosmetics and nutrition supplement world. It exposes a core flaw: placebo response, expectation bias, and regression to the mean can produce statistically "significant" improvements even with a biologically inert product - especially when:
- There is no blinded control group
- The outcome is a self-reported questionnaire ("does your skin feel smoother?")
- The assessor knows which product was applied
- The study is funded by the company whose product is being tested
Part 2: Separating "Topical Vitamin C" from "Ethyl Ascorbic Acid" - These Are NOT the Same Evidence Base
This is probably the most important point in your question. The evidence pyramid for vitamin C on skin looks like this - and you have to read it carefully:
A) L-Ascorbic Acid (Pure vitamin C) - Moderate evidence, with genuine RCTs
The best evidence for topical vitamin C on skin comes from studies using pure L-ascorbic acid (L-AA) at 5-20% concentrations:
-
Humbert et al. (2003, PMID 12823436) - A double-blind, randomized, placebo-controlled trial in 20 volunteers. Applied 5% vitamin C cream vs. excipient (placebo) on opposite sides of the forearm for 6 months. Used dermatologist clinical assessment + skin biopsies with immunohistochemistry and electron microscopy - not just questionnaires. Found significant improvement in skin microrelief, deep furrows, and ultrastructural elastic tissue repair. This is Tier 3 evidence but with objective, biopsy-level corroboration. Funding: not industry-sponsored in the way you describe.
-
Nusgens et al. (2001, PMID 11407971) - RCT in 10 postmenopausal women. Measured collagen I and III mRNA via reverse transcription-PCR from actual skin biopsies. Found measurable upregulation of collagen synthesis genes. This is molecular/mechanistic evidence from actual human tissue - not a questionnaire.
-
Fitzpatrick & Rostan (2002) - A double-blind, half-face study with 10 subjects using 10% topical vitamin C for 12 weeks. Showed statistically significant reduction in photoageing scores vs. placebo - published in Dermatologic Surgery.
These studies are small (10-20 subjects), but they use objective endpoints (biopsies, mRNA quantification, electron microscopy, validated clinical scales) rather than just "how does your skin feel?" questionnaires. They are genuinely controlled studies.
B) 3-O-Ethyl Ascorbic Acid (EAA) - Much Weaker Evidence
Here is where your concern hits hardest. The evidence for ethyl ascorbic acid specifically is substantially weaker:
-
Skin penetration: One 2019 study (PMC6733298) characterized EAA's penetration in porcine skin in vitro using Franz diffusion cells. This is not human clinical data - it's an ex vivo lab model.
-
Brightening/whitening: The available clinical data comes largely from a manufacturer-associated PDF studying ITA° (individual typology angle) measurements in 28-day studies with small cohorts. The outcomes, while somewhat objective (chromameter readings), often lack published peer review in high-impact journals and lack independent replication.
-
Collagen stimulation in humans: As Chemist Confessions puts it directly: "We couldn't find any clinicals that test 3-O-ethyl products directly on human skin" for collagen/anti-aging benefits. The collagen data is from in vitro fibroblast cell cultures - not human skin.
-
Antioxidant activity in skin: Largely in vitro.
So when a brand says "ethyl ascorbic acid provides vitamin C's collagen-boosting benefits" - that claim is being extrapolated from the L-ascorbic acid evidence base and applied to a derivative without equivalent human clinical proof. The mechanism is plausible (EAA is supposed to be cleaved to L-AA in the skin), but the degree of actual conversion in living human skin, at what rate, in what quantities, is not well-established in published independent studies.
Part 3: Key Problems with the Broader Topical Vitamin C Literature
Even the better studies have significant limitations:
-
Sample sizes are tiny - most RCTs have 10-20 subjects, giving very low statistical power and high risk of chance findings
-
Most positive studies originate from the same research groups - Humbert, Haftek, Nusgens repeat across multiple papers, representing a narrow base of independent replication
-
Publication bias - negative results (product didn't work) are rarely published, especially when industry-funded
-
Formulation variability - L-AA requires pH 2.5-3.5 and specific stabilization to remain effective; studies using suboptimal formulations might show no effect; studies using optimized formulations funded by the manufacturer of that optimized formula will naturally show better results
-
The "funded by the brand" problem - SkinCeuticals (L'Oreal subsidiary) has funded several of the better-known L-AA studies, including the Pinnell percutaneous absorption work. Their findings are real but need to be evaluated with that context in mind
-
No large independent RCTs - There is no equivalent of a pharmaceutical-level, large multi-center, independently funded RCT for topical vitamin C the way there is for, say, a blood pressure drug
Part 4: Bottom Line Verdict
| Claim | Evidence Strength | Notes |
|---|---|---|
| L-AA (pure vitamin C) increases collagen mRNA in skin | Moderate - small RCTs with biopsies | Replicated by >1 group, uses objective endpoints |
| L-AA improves photodamage vs. placebo | Moderate - double-blind RCTs | Still small studies, some industry funding |
| L-AA absorbs into skin at correct pH | Good - Pinnell 2001 absorption data | Well-characterized |
| Ethyl ascorbic acid absorbs into human skin in vivo | Weak - only porcine in vitro data | Extrapolated from solvent studies |
| Ethyl ascorbic acid boosts collagen in human skin | Very weak - in vitro fibroblasts only | No human clinical RCT data found |
| Ethyl ascorbic acid brightens skin in humans | Weak-moderate - small, often manufacturer-funded studies with chromameter | Some objective measurement but limited independence |
Your skepticism is well-placed. The L-ascorbic acid evidence is real but limited in scale and replication. The ethyl ascorbic acid evidence for anti-aging and collagen benefits in actual human skin is largely extrapolated from cell culture or from the L-AA literature, with very few independent, placebo-controlled human studies - and none at a level that would satisfy pharmaceutical regulatory standards.
The type of "clinical testing" company you described - that would pass a fake product through their system - is almost certainly running the exact category of study that sits below even the weakest tier of the evidence pyramid: no controls, questionnaire-only outcomes, no blinding, funded by the client. Those "studies" generate marketing claims, not scientific evidence.
This is a shared conversation. Sign in to Orris to start your own chat.